Does TREOSULFAN Cause Malignant neoplasm progression? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Malignant neoplasm progression have been filed in association with TREOSULFAN (GRAFAPEX). This represents 0.3% of all adverse event reports for TREOSULFAN.
5
Reports of Malignant neoplasm progression with TREOSULFAN
0.3%
of all TREOSULFAN reports
0
Deaths
0
Hospitalizations
How Dangerous Is Malignant neoplasm progression From TREOSULFAN?
Of the 5 reports.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREOSULFAN. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does TREOSULFAN Cause?
Off label use (418)
Cytomegalovirus infection (211)
Mucosal inflammation (199)
Cytomegalovirus infection reactivation (190)
Adenovirus infection (168)
Product use in unapproved indication (161)
Acute graft versus host disease in skin (145)
Drug ineffective (117)
Graft versus host disease in skin (109)
Human herpesvirus 6 infection (104)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which TREOSULFAN Alternatives Have Lower Malignant neoplasm progression Risk?
TREOSULFAN vs TREPROSTINIL
TREOSULFAN vs TREPROSTINIL DIOLAMINE
TREOSULFAN vs TRETINOIN
TREOSULFAN vs TRIAMCINOLONE
TREOSULFAN vs TRIAMCINOLONE ACETONIDE